Do social functioning and symptoms improve with continuation antidepressant treatment of persistent depressive disorder? An observational study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Do social functioning and symptoms improve with continuation antidepressant treatment of persistent depressive disorder? An observational study

Published:2017-03 Issue: Volume:210 Page:258-264
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Hellerstein David J.,Hunnicutt-Ferguson Kallio,Stewart Jonathan W.,McGrath Patrick J.,Keller Samantha,Peterson Bradley S.,Chen Ying

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference54 articles.

1. Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression;Agosti;J. Affect. Disord.,2002

2. The A–B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests;Aldenkamp;Seizure,2002

3. The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests;Aldenkamp;Seizure,2002

4. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder;Bakish;J. Clin. Psychopharmacol.,1993

5. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years;Barrett;J. Fam. Pract.,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in the treatment of dysthymia: a narrative review;Expert Review of Neurotherapeutics;2024-05-28

2. The clinical effectiveness of a self-management intervention for patients with persistent depressive disorder and their partners/caregivers: results from a multicenter, pragmatic randomized controlled trial;Trials;2024-03-13

3. Co-administration of saffron and chamomile: to determine the efficacy as an adjuvant therapy for mild to moderate depression in human subjects. A pilot randomized clinical trial;Journal of the Pakistan Medical Association;2023-05-15

4. Differences in gray matter volumes of subcortical nuclei between major depressive disorder with and without persistent depressive disorder;Journal of Affective Disorders;2023-01

5. Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder;Frontiers in Psychiatry;2019-10-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3